| Feb 12, 2024 |
Feb 14, 2024 |
ENANTA PHARMACEUTICALS INC
|
Chief Legal Officer |
Sell |
78.8
|
+2,347
|
2.25%
|
✗
|
$12.1K |
| Dec 5, 2023 |
Dec 6, 2023 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
46.3
|
-2,412
|
-2.26%
|
✗
|
$23.2K |
| Dec 1, 2023 |
Dec 5, 2023 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
46.3
|
-1,595
|
-1.48%
|
✗
|
$15.1K |
| Feb 13, 2023 |
Feb 15, 2023 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
97.5
|
+14,262
|
16.36%
|
✗
|
$355.4K |
| Dec 1, 2022 |
Dec 5, 2022 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
46.3
|
-1,055
|
-1.20%
|
✗
|
$46.8K |
| Feb 14, 2022 |
Feb 15, 2022 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
87.5
|
+2,077
|
3.19%
|
✗
|
$59.8K |
| Dec 1, 2021 |
Dec 3, 2021 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
48.8
|
-557
|
-0.85%
|
✗
|
$48.8K |
| Dec 15, 2020 |
Dec 16, 2020 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
42.5
|
-1,540
|
-2.55%
|
✗
|
$65.5K |
| Feb 12, 2020 |
Feb 18, 2020 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
83.8
|
+1,947
|
4.95%
|
✗
|
$49.6K |
| Dec 16, 2019 |
Jan 6, 2020 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
42.5
|
-2,331
|
-5.60%
|
✗
|
$148.9K |
| Feb 12, 2019 |
Feb 13, 2019 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
97.5
|
+6,151
|
34.50%
|
✓
|
$718.5K |
| Feb 12, 2018 |
Feb 13, 2018 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
95.0
|
+4,757
|
62.84%
|
✗
|
$158.7K |
| Feb 13, 2017 |
Feb 15, 2017 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Sell |
91.3
|
+1,370
|
72.11%
|
✗
|
$24.7K |
| May 11, 2016 |
May 12, 2016 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Buy |
91.3
|
+500
|
35.71%
|
✗
|
$12.2K |
| Feb 13, 2015 |
Feb 17, 2015 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & General Counsel |
Buy |
91.3
|
+1,400
|
100.00%
|
✗
|
$46.5K |